Collegium Pharmaceutical, Inc. (COLL)
Nasdaq: COLL · Pharmaceutical Preparations · Stoughton, MA · filing with the SEC since 2003
Grade6.4
◀ Past 7.8● Present 6.1▶ Future 5.4
Filings
304 filings since 2017 beside 433 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 7, 2026.
Filings a yearinsider forms included
72857169567511268
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest May 12, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 6, 2026
8-K items 2.02, 7.01
Results released; Investor disclosure (Regulation FD) · Current report
Jun 30, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
May 12, 2026
May 12, 2026
8-K items 2.01, 5.02, 7.01, 9.01
Purchase or sale of a business completed; Officer or director change; Investor disclosure (Regulation FD) · Current report
May 7, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Mar 19, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Feb 26, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Dec 30, 2025
8-K items 1.01, 1.02, 3.02, 7.01, 9.01
Major agreement signed; Major agreement ended; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Dec 23, 2025
40 of 304 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.